Jo Halliday, chief executive of Talking Medicines By Kristy Dorsey Scottish data tech company Talking Medicines has launched its new service providing marketing intelligence to the pharmaceutical industry. Using text mining technologies, PatientMetRx collects data from sites such as Reddit, Twitter, online forums and blogs to produce a systematic measurement of patients’ experience of taking medicines. This data is filtered by artificial intelligence (AI) developed by Talking Medicines that removes irrelevant information to focus on what it being said about medicines, health conditions, symptoms and so forth. Drawing from what the company claims are “millions of conversations”, this information is mapped against a database of 130,000 globally-regulated medicines to produce a “patient confidence score”, offering a systematic way of understanding trending patient trust in their drug brands.
Talking Medicines Launches AI-Powered Patient Intelligence Platform to Revolutionize Marketing for World s Leading Drug Brands
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210204005476/en/
Jo Halliday CEO Talking Medicines (Photo: Business Wire)
PatientMetRx uses AI to provide a systematic way of measuring patients experience of taking medicines.
Powered by EVA, a proprietary AI machine developed by Talking Medicines, PatientMetRx combines Machine Learning and Natural Language Processing to capture the voice of the patient from millions of conversations taking place over multiple sources including social media, forums and blogs, mapped to a curated database of 130,000 regulated global medicines. It distils what patients are saying online and more importantly, what they are feeling, into powerful data insights which are fully pharma compliant.